881. Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

BACKGROUND: Symptoms during acute COVID-19 can limit daily activities and delay return to work and school. Little is known about the association between SARS-CoV-2 burden in either the upper airway or plasma and the duration of COVID-19 symptoms. METHODS: ACTIV-2/A5401 is a platform trial for COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yijia, Harrison, Linda J, Chew, Kara W, Eron, Joseph J, Daar, Eric S, Wohl, David A, Wu, Ryan, Moser, Carlee, Ritz, Justin, Giganti, Mark, Javan, Arzhang Cyrus, Coombs, Robert, Hughes, Michael D, Currier, Judith S, Smith, Davey M, Li, Jonathan Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752138/
http://dx.doi.org/10.1093/ofid/ofac492.074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752138/
http://dx.doi.org/10.1093/ofid/ofac492.074

Ejemplares similares